Mirum Pharmaceuticals, Inc. (MIRM): 5 insider purchases in the last two years (1 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jan 27, 2026 | Heron Patrick J Director | 131,425 | $68.48 | $9.0M | opportunistic |
| Mar 18, 2025 | Heron Patrick J Director | 549 | $44.10 | $24.2K | no history |
| Mar 12, 2025 | Heron Patrick J Director | 2,298 | $43.30 | $99.5K | no history |
| Mar 10, 2025 | Heron Patrick J Director | 1,915 | $43.68 | $83.7K | no history |
| Mar 6, 2025 | Heron Patrick J Director | 1,602 | $45.40 | $72.7K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.